(Q44515038)

3 December 2017

title

Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice (English)

1 reference

3 December 2017

0 references

1

1 reference

3 December 2017

Jolanta Parada-Turska

series ordinal

3

object named as

Jolanta Parada-Turska

1 reference

3 December 2017

Stanisław Jerzy Czuczwar

series ordinal

4

object named as

Stanisław J Czuczwar

1 reference

3 December 2017

2

Mariusz Swiader

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

3 December 2017

published in

Neuropsychopharmacology

1 reference

3 December 2017

volume

28

1 reference

3 December 2017

issue

10

1 reference

3 December 2017

page(s)

1817-1830

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300243

3 December 2017

exact match

0 references

cites work

Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

International experience with tiagabine add-on therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Antiepileptic drug combinations and experimental background: the case of phenobarbital and phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Important pharmacokinetic properties of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

21 January 2018

Reducing overtreatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Do we need any more new antiepileptic drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Polytherapy in epilepsy: the experimental evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

The new generation of GABA enhancers. Potential in the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Overtreatment in adults with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Current limitations of antiepileptic drug therapy: a conference review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Rapid initiation of gabapentin: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Overtreatment in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Tiagabine antinociception in rodents depends on GABA(B) receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Trimethoprim and rifampicin: in vitro activities separately and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Pre- rather than co-application of vigabatrin increases the efficacy of tiagabine in hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Neurochemical actions of gabapentin in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Effects of tiagabine and vigabatrin on GABA uptake into primary cultures of rat cortical astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Differential cognitive effects of carbamazepine and gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Effects of gabapentin on cognition and quality of life in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Primary Generalized Epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Treatment of painful sensory neuropathy with tiagabine: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

21 January 2018

GABA and epileptogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Tiagabine (gabitril) experience in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Overtreatment in epilepsy: adverse consequences and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Antiepileptic drugs as a cause of worsening seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Pharmacokinetic interactions of the new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Gabapentin in phantom limb pain management in children and young adults: report of seven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Strategies to prevent overtreatment with antiepileptic drugs in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Pharmacological overtreatment in epilepsy: mechanisms and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Tiagabine, a gamma-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Spinal gabapentin is antinociceptive in the rat formalin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Gabapentin increases the hyperpolarization-activated cation current Ih in rat CA1 pyramidal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Statistical analysis of drug combinations for synergism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

The interaction index: a measure of drug synergism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

A summary of mechanistic hypotheses of gabapentin pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

The Long-Term Use of Gabapentin, Lamotrigine, and Vigabatrin in Patients with Chronic Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Combined administration of carbamazepine and phenobarbital: effect on anticonvulsant activity and neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Alternative uses of lamotrigine and gabapentin in the treatment of trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Gabapentin in generalized seizures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Aggravation of focal epileptic seizures by antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Animal models of the epilepsies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Synergism with GABAergic drugs in refractory epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Seizure-associated headache in epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Do antiepileptic drugs exacerbate seizures?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Painful auras in focal epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Single Drug or Combination Therapy for Epilepsy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Headache and epilepsy: two autonomous entities?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Tiagabine monotherapy in the treatment of partial epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Tiagabine and non-convulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

EFFICIENT DESIGNS FOR STUDYING SYNERGISTIC DRUG COMBINATIONS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300243

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300243

1 reference

Dimensions Publication ID

3 December 2017

1050440084

0 references

1 reference